[1]
R. Costa Leite Lucio Silva and M. A. Estrin, “Cardiovascular risk associated with the use of selective COX-2 inhibitors: a systematic review”, Interamerican Journal of Health Sciences, no. 2, p. 118, Dec. 2022.